ClinicalTrials.Veeva

Find clinical trials for Pancreatic Cancer in Detroit, MI

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Cancer
Carcinoma
Colorectal Cancer
Lung Cancer
Non-Small-Cell Lung Carcinoma
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near Detroit, MI, USA:

Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer

receiving lower radiation doses, in patients with locally advanced pancreatic cancer, without increasing the rate of serious gastro...

Active, not recruiting
Pancreatic Cancer
Radiation: Stereotactic MRI-guided On-table Adaptive Radiation Therapy
ViewRay

Detroit, Michigan, United States and 12 other locations

with either gemcitabine plus nab-paclitaxel (G/NP) or FOLFIRINOX in the treatment of participants with locally advanced, unresectable pancreatic...

Active, not recruiting
Pancreatic Cancer Non-resectable
Drug: Pamrevlumab + Gemcitabine + Nab-paclitaxel or Pamrevlumab + FOLFIRINOX
Drug: Placebo + Gemcitabine + Nab-paclitaxel or Placebo + FOLFIRINOX

Phase 3

FibroGen
FibroGen

Detroit, Michigan, United States and 89 other locations

ONIVYDE + LV + 5-FU chemotherapy regimen in patients with advanced pancreatic cancer and to determine the recommended dose for the ...

Active, not recruiting
Pancreatic Cancer
Biological: XB2001 or Placebo

Phase 1, Phase 2

XBiotech

Detroit, Michigan, United States of America and 27 other locations

open label, multi-center, clinical study of Chimeric Antigen Receptor T Cells (CAR-T) targeting claudin18.2 in patients with advanced gastric, pancreatic...

Active, not recruiting
Gastric Cancer
Pancreatic Cancer
Biological: CT041

Phase 1, Phase 2

CARsgen Therapeutics

Detroit, Michigan, United States and 15 other locations

in first line treatment naïve subjects with Stage IV metastatic pancreatic carcinoma. The first part of study will focus on the treatment of ...

Active, not recruiting
Pancreatic Neoplasm
Drug: Antroquinonol

Phase 1, Phase 2

Golden Biotechnology

Detroit, Michigan, United States and 8 other locations

compared to just chemotherapy alone in participants with metastatic pancreatic cancer. One group of participants will only receive ...

Enrolling
Metastatic Pancreatic Ductal Adenocarcinoma
Drug: Nab-paclitaxel
Drug: Gemcitabine

Phase 2

Agenus
Agenus

Ann Arbor, Michigan, United States and 33 other locations

This proposed Phase I clinical trial of SON-DP is an FIH, open-label, Phase Ia/Ib dose escalation and expansion study to evaluate the safety, tolerab...

Enrolling
Breast Cancer
Ovarian Cancer
Drug: SON-DP

Phase 1

Qurgen Inc.

Detroit, Michigan, United States and 4 other locations

or without SBP-101 in subjects previously untreated for metastatic pancreatic ductal adenocarcinoma (PDA), including subjects who have recei...

Enrolling
Pancreatic Cancer Metastatic
Pancreatic Cancer Stage IV
Drug: Gemcitabine
Drug: Nab-paclitaxel

Phase 2, Phase 3

Panbela Therapeutics

Detroit, Michigan, United States and 91 other locations

This is a nonrandomized, uncontrolled, open-label, multicenter Phase 2 study to evaluate the efficacy, safety, and tolerability of futibatinib in com...

Enrolling
Siewert Type 1 GEJ Cancer
Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal Cancer
Drug: Leucovorin
Drug: Futibatinib

Phase 2

Taiho Pharma
Taiho Pharma

Detroit, Michigan, United States and 21 other locations

This trial will study tisotumab vedotin to find out whether it is an effective treatment for certain solid tumors and what side effects (unwanted eff...

Enrolling
Exocrine Pancreatic Cancer
Carcinoma, Non-Small-Cell Lung
Drug: cisplatin
Drug: carboplatin

Phase 2

Seagen
Seagen

Detroit, Michigan, United States and 60 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems